Clinical Trials Research Alliance (CTRA)

Necrotizing Soft Tissue Infections Study

About this Trial

Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections (ACCUTE)

  • Status: Enrolling now
  • Location: Miami Valley Hospital
  • Study type: Interventional
  • Ages eligible for study: 18 and older
  • Genders eligible for study: Both
  • Principal Investigator: Akpofure Peter Ekeh, M.D.
  • For more information about this study, visit NCT02469857

If you would like information about participating in this study, contact:

Contact us

Linda Clark, MSN, RN
(937) 208-2913

Last edited on 01/11/2019.